Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Tax Provisions (2016 - 2026)

Pharma-Bio Serv's Tax Provisions history spans 17 years, with the latest figure at $3630.0 for Q1 2026.

  • For Q1 2026, Tax Provisions rose 225.56% year-over-year to $3630.0; the TTM value through Jan 2026 reached $18276.0, up 76.78%, while the annual FY2025 figure was $6203.0, 72.02% down from the prior year.
  • Tax Provisions reached $3630.0 in Q1 2026 per PBSV's latest filing, down from $4356.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $168040.0 in Q2 2023 to a low of -$30960.0 in Q4 2024.
  • Average Tax Provisions over 5 years is $35326.4, with a median of $19004.0 recorded in 2024.
  • Peak YoY movement for Tax Provisions: soared 273.36% in 2023, then tumbled 4406.55% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $57665.0 in 2022, then tumbled by 101.19% to -$687.0 in 2023, then crashed by 4406.55% to -$30960.0 in 2024, then soared by 114.07% to $4356.0 in 2025, then decreased by 16.67% to $3630.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Tax Provisions are $3630.0 (Q1 2026), $4356.0 (Q4 2025), and $4779.0 (Q3 2025).